Lupin Strikes Deal In Suit Over Generic Lunesta

Law360 (January 3, 2011, 4:11 PM EST) -- Lupin Ltd. on Monday announced that it had reached a settlement with Sunovion Pharmaceuticals Inc. in a lawsuit over a generic version of the sleep aid Lunesta.

Under the settlement, Lupin and its subsidiary, Lupin Pharmaceuticals Inc., would be able to sell a generic version of Lunesta by the end of November 2013, approximately two months before the expiration of one of the patents-in-suit, 6,444,673.

If Sunovion receives six months of additional pediatric exclusivity for Lunesta, the licensing agreement would go into effect at the end...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.